CRISPR-Cas13 system as a promising and versatile tool for cancer diagnosis, therapy, and research

F Palaz, AK Kalkan, O Can, AN Demir… - ACS Synthetic …, 2021 - ACS Publications
Over the past decades, significant progress has been made in targeted cancer therapy. In
precision oncology, molecular profiling of cancer patients enables the use of targeted cancer …

Massively parallel Cas13 screens reveal principles for guide RNA design

HH Wessels, A Méndez-Mancilla, X Guo, M Legut… - Nature …, 2020 - nature.com
Type VI CRISPR enzymes are RNA-targeting proteins with nuclease activity that enable
specific and robust target gene knockdown without altering the genome. To define rules for …

Principles for rational Cas13d guide design

HH Wessels, A Méndez-Mancilla, X Guo, M Legut… - bioRxiv, 2019 - biorxiv.org
Type VI CRISPR enzymes have recently been identified as programmable RNA-guided,
RNA-targeting Cas proteins with nuclease activity that allow for specific and robust target …